|
|
16 Technology Drive, Suite 118
Irvine, CA 92618 USA
phone:
(949) 753-7844
fax:
(949) 753-7845 |
| Symbol |
Private |
| Founded |
0 |
| Employees |
|
|
|
www.neomatrix.com |
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Fully automated, noninvasive breast disease screening device. |
 |
| Management |
| John Stroh, President and CEO |
|
|
|
|
| Keywords |
| women's health, women's, womenshealth, advamed, j2008 |
|
|
|
|
Description |
| NeoMatrix develops devices that allow women and their doctors to promote optimal breast health. The company's premier product, the HALO Breast Pap Test, is the only fully automated, noninvasive breast disease screening device designed for use in the Primary Care setting as part of an annual well-woman visit. |
 |
| Products / Services |
With the HALO Breast Cancer Test, adjustable cups are fitted to the woman's breasts. The test cycle is then started and the system automatically warms the breasts, gently massages them, and applies light suction to bring nipple aspirate fluid to the surface of the nipple. The nipple aspirate fluid is then collected, placed into a standard liquid cytology vial, and sent to a cytology laboratory for analysis. The entire procedure is well-tolerated by patients, with no anesthetic required.
|
 |
| Technology / Differentiation |
| The HALO Breast Pap Test has been FDA approved for the collection of nipple aspirate fluid for cytologic evaluation. The collected fluid can be used in the determination and differentiation of normal cells versus pre-malignant or malignant cells.
|
 |
| Market / Customers |
In the US we spend $3 billion annually on breast cancer screening, yet more than 70% of lumps are discovered during self-exams. Unfortunately, by the time a woman can actually feel the lump, the disease is no longer in its earliest, most treatable stage.
|
 |
|
|
|
|